Invention Grant
US08258143B2 Methods of using substituted pyrrolo[2,3-d]pyrimidines for targeting tumor cells and treating cancer
有权
使用取代的吡咯并[2,3-d]嘧啶靶向肿瘤细胞和治疗癌症的方法
![Methods of using substituted pyrrolo[2,3-d]pyrimidines for targeting tumor cells and treating cancer](/docs/US/2012-09-04/US08258143B2/abs.jpg.600x600.jpg)
- Patent Title: Methods of using substituted pyrrolo[2,3-d]pyrimidines for targeting tumor cells and treating cancer
- Patent Title (中): 使用取代的吡咯并[2,3-d]嘧啶靶向肿瘤细胞和治疗癌症的方法
-
Application No.: US11820872Application Date: 2007-06-21
-
Publication No.: US08258143B2Publication Date: 2012-09-04
- Inventor: Aleem Gangjee , Larry H Matherly
- Applicant: Aleem Gangjee , Larry H Matherly
- Applicant Address: US PA Pittsburgh US MI Detroit
- Assignee: Duquesne University of the Holy Ghost,Wayne State University
- Current Assignee: Duquesne University of the Holy Ghost,Wayne State University
- Current Assignee Address: US PA Pittsburgh US MI Detroit
- Agency: Buchanan Ingersoll & Rooney PC
- Agent Craig G. Cochenour
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; A61P35/04
![Methods of using substituted pyrrolo[2,3-d]pyrimidines for targeting tumor cells and treating cancer](/abs-image/US/2012/09/04/US08258143B2/abs.jpg.150x150.jpg)
Abstract:
A method for treating cancer tumors, particularly ovarian cancer tumors, is described, where fused cyclic pyrimidine having a cancer treating ability is selectively delivered to an FR expressing cancerous tumor.
Public/Granted literature
- US20080045552A1 Methods of using selective chemotherapeutic agents for targeting tumor cells Public/Granted day:2008-02-21
Information query
